Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...
Cambridge-based genomics and drug discovery fledgling OutSee has closed its £2.5 million seed round and signed a strategic ...
A Cambridge-based firm which applies AI predictive genomics to drug target discovery has completed a £2.5m seed funding round and signed a new partnership.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback